Wells Fargo & Company Precision Biosciences Inc Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.29 - $0.45 $16 - $25	57 Added 0.74%	7,728 $2,000
Q3 2023 Nov 13, 2023	BUY	$0.34 - $0.69 $2 - $4	6 Added 0.08%	7,671 $2,000
Q2 2023 Aug 15, 2023	SELL	$0.52 - $0.91 $135 - $236	-260 Reduced 3.28%	7,665 $4,000
Q1 2023 May 12, 2023	BUY	$0.7 - $1.41 $215 - $434	308 Added 4.04%	7,925 $5,000
Q4 2022 Feb 13, 2023	SELL	$0.97 - $45.0 $2,481 - $115,110	-2,558 Reduced 25.14%	7,617 $9,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $962 - $32,191	-789 Reduced 7.2%	10,175 $13,000
Q2 2022 Aug 12, 2022	SELL	$1.15 - $3.34 $66,405 - $192,864	-57,744 Reduced 84.04%	10,964 $18,000
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $47,185 - $123,702	-15,941 Reduced 18.83%	68,708 $211,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $348,591 - $549,267	-47,107 Reduced 35.75%	84,649 $626,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $594,010 - $915,604	64,707 Added 96.51%	131,756 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $8,715 - $13,521	1,080 Added 1.64%	67,049 $840,000
Q1 2021 May 13, 2021	SELL	$8.57 - $15.79 $137,797 - $253,887	-16,079 Reduced 19.6%	65,969 $682,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $12.47 $36,155 - $75,393	6,046 Added 7.96%	82,048 $685,000
Q3 2020 Nov 05, 2020	SELL	$4.65 - $8.73 $74,906 - $140,631	-16,109 Reduced 17.49%	76,002 $468,000
Q2 2020 Aug 13, 2020	SELL	$4.66 - $8.7 $117,264 - $218,926	-25,164 Reduced 21.46%	92,111 $768,000
Q1 2020 May 14, 2020	BUY	$5.05 - $15.01 $592,238 - $1.76 Million	117,275 New	117,275 $706,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.